Losartan 50 mg Three Times Daily Is Not Appropriate
Losartan should never be dosed at 50 mg three times daily (150 mg total) because the FDA-approved maximum dose is 100 mg once daily for hypertension, and guideline-recommended dosing is either once daily or split into twice-daily administration—never three times daily. 1, 2
FDA-Approved Dosing Parameters
- The FDA label explicitly states that the usual starting dose is 50 mg once daily, with a maximum dose of 100 mg once daily for hypertension 1
- The maximum recommended daily dose of losartan is 100 mg, which can be given as a once-daily dose or by splitting the same total daily dose into two doses 3
- The American College of Cardiology/American Heart Association guidelines list losartan's usual dose range as 50–100 mg/day with a daily frequency of "1 or 2"—meaning once or twice daily, not three times daily 2
Why Three-Times-Daily Dosing Is Inappropriate
- Pharmacokinetic profile does not support TID dosing: Losartan's active metabolite E-3174 has a terminal half-life of 6–9 hours, which supports once- or twice-daily dosing but does not require three-times-daily administration 3
- Exceeds maximum approved dose: Three doses of 50 mg would total 150 mg daily, which exceeds the FDA-approved maximum of 100 mg daily for hypertension 1
- No clinical trial evidence: The pivotal trials (OPTIMAAL, VALIANT, HEAAL) used once-daily or twice-daily dosing regimens; there is no evidence base for three-times-daily administration 4, 2
Correct Dosing Strategies
For Hypertension
- Start at 50 mg once daily and increase to 100 mg once daily if blood pressure remains ≥140/90 mmHg after 2–4 weeks 1, 5
- If twice-daily dosing is desired for more consistent 24-hour coverage, split the 100 mg total daily dose into 50 mg twice daily 2
- If blood pressure remains uncontrolled on losartan 100 mg daily, add hydrochlorothiazide 12.5–25 mg daily rather than exceeding the maximum losartan dose 2, 5
For Heart Failure with Reduced Ejection Fraction
- The target dose is 100–150 mg once daily based on the HEAAL trial, which demonstrated that 150 mg daily was superior to 50 mg daily with a 10% relative risk reduction in death or heart failure hospitalization 2
- The European Society of Cardiology recommends 150 mg daily as the target dose for heart failure, administered as a single daily dose 2
For Diabetic Nephropathy
- Start at 50 mg once daily and increase to 100 mg once daily based on blood pressure response 1
- The target dose for diabetic nephropathy is 100 mg once daily 2
Common Pitfall to Avoid
Do not confuse losartan dosing with captopril dosing. The OPTIMAAL and VALIANT trials used captopril 50 mg three times daily as the comparator, but losartan was dosed at 50 mg once daily (OPTIMAAL) or up to 160 mg twice daily for valsartan (VALIANT)—never three times daily 4. This confusion may arise from misreading trial protocols where captopril's TID regimen is mistakenly applied to losartan.
What to Do Instead
- If the patient requires better blood pressure control on losartan 50 mg once daily, increase to 100 mg once daily 5, 1
- If 100 mg once daily is insufficient, add a thiazide diuretic (hydrochlorothiazide 12.5–25 mg daily) or a dihydropyridine calcium channel blocker (amlodipine 5–10 mg daily) 2, 5
- If twice-daily dosing is preferred for pharmacokinetic reasons, use 50 mg twice daily (total 100 mg/day), not 50 mg three times daily 2, 3
Critical Safety Monitoring
- Check serum creatinine/eGFR and potassium within 1–2 weeks after initiating or increasing losartan dose, especially in patients with diabetes or chronic kidney disease 2, 5
- Never combine losartan with ACE inhibitors or direct renin inhibitors (aliskiren), as dual RAAS blockade increases the risk of hyperkalemia, syncope, and acute kidney injury by 2–3-fold without cardiovascular benefit 2, 5